Core Viewpoint - The announcement details a change in shareholding for Chongqing Shanwaishan Blood Purification Technology Co., Ltd., indicating a decrease in the shareholding percentage of major shareholders, which may impact the company's governance structure and market perception [1][4]. Group 1: Shareholding Changes - Major shareholder Hunan Xiangjiang Liyuan Investment Management Co., Ltd. and its associated entities have reduced their combined shareholding from 12.87% to 12.00% [1][2]. - The reduction involved the sale of 1,937,703 shares, representing 0.60% of the total share capital, and an additional sale of 850,300 shares, accounting for 0.26% of the total share capital [1][2]. - The shareholding changes were executed through centralized bidding transactions between June 6, 2025, and July 11, 2025 [2]. Group 2: Compliance and Governance - The company confirms that the shareholding changes do not violate any prior commitments or plans made by the shareholders [1][4]. - The announcement assures that the changes will not lead to a shift in the controlling shareholder or actual controller, thus maintaining the company's governance structure [2][4]. - The company has adhered to relevant regulations regarding shareholder reductions, ensuring compliance with the applicable laws and guidelines [4].
山外山: 关于持股5%以上股东权益变动触及1%刻度的提示性公告